Interestingly, increased numbers of intra‐epithelial CD8+ cells and PD‐L1+ immune cells were observed in the post‐therapy tumour sample compared with pre‐surgery, and this increase was more pronounced in responders than in patients who relapsed. The gene discussed is CD8A; the disease is neoplasm.